At ECTRIMS, we presented our latest advancements in Multiple Sclerosis (MS).
Here is the video of our presentation:
Download the ECTRIMS 2024 presentation slides
Our Healthcare Program Director, Damien Eggenspieler, and Healthcare Partnerships Lead, Yacine Bechichi attended the conference.
For years, clinical trials in achondroplasia have relied heavily on annual growth velocity as the primary outcome measure. However, height alone doesn’t tell the full
In July 2023, the European Medicines Agency (EMA) granted qualification to SV95C (Stride Velocity 95th Centile) as a primary endpoint for clinical trials in ambulatory
How do you assess a patient too young to follow instructions? That’s the challenge our Program Director, Damien Eggenspieler, tackled on the ground at ICNMD
